| 12195448 |
Substituted pyrazolo piperidine carboxylic acids |
Alexandros Vakalopoulos, Marie-Pierre Collin-Kröpelin, Nuria ORTEGA HERNANDEZ, Andre DIESKAU, Melissa BOULTADAKIS-ARAPINIS +9 more |
2025-01-14 |
| 11684621 |
Combination containing sGC stimulators and mineralocorticoid receptor antagonists |
Peter Kolkhof |
2023-06-27 |
| 11508483 |
Method of identifying a subgroup of patients suffering from dcSSc which benefits from a treatment with sGC stimulators and sGC activators in a higher degree than a control group |
Melanie Hemmrich, Janethe de Oliveira Pena, Stephen Dawe |
2022-11-22 |
| 11439628 |
Use of non-steroidal mineralocorticoid receptor antagonists alone or in combination for the treatment of muscular or neuromuscular diseases |
Peter Kolkhof, Ilka MATHAR, Stefanie Breitenstein |
2022-09-13 |
| 11331308 |
Combination containing sGC activators and mineralocorticoid receptor antagonists |
Peter Kolkhof |
2022-05-17 |
| 10918639 |
Combination containing SGC stimulators and mineralocorticoid receptor antagonists |
Peter Kolkhof |
2021-02-16 |
| 10265314 |
SGC stimulators in combination with additional treatment for the therapy of cystic fibrosis |
Johannes-Peter Stasch, Michael Hahn, Markus Follmann |
2019-04-23 |
| 10189856 |
Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc) |
Claudia Hirth-Dietrich, Johannes-Peter Stasch, Andreas Knorr, Georges Von Degenfeld, Michael Hahn +1 more |
2019-01-29 |
| 9040566 |
Adenosine A1 agonists for the treatment of glaucoma and ocular hypertension |
Jürgen Klar, Georges Von Degenfeld, Hans-Georg Lerchen, Barbara Albrecht-Küpper, Andreas Knorr +1 more |
2015-05-26 |
| 8304406 |
Compounds for treating pulmonary hypertension |
Martina Susanne Klein, Reiner Frey, Bernd Riedl, Olaf Christensen |
2012-11-06 |